| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2901064 | Chest | 2013 | 8 Pages |
Abstract
The use of once-daily enoxaparin regimen as control in clinical trials will lead to more favorable estimates of relative efficacy for the new oral anticoagulants than if enoxaparin 30 mg bid had been chosen as a comparator.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chun Shing MBBS, Shiva MBBS, Jessica Ka-yan MBBS, Yoon K. MD,